An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
NCT06169397
·
clinicaltrials.gov ↗
PHASE2
Phase
ENROLLING_BY_INVITATION
Status
94
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Sarcoidosis
Interventions
DRUG:
XTMAB-16
Sponsor
Xentria, Inc.